2011
DOI: 10.1111/j.1365-2133.2011.10475.x
|View full text |Cite
|
Sign up to set email alerts
|

Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis

Abstract: Our results indicate that FLG loss-of-function-variants are less common in patients with IV and AD in the Ethiopian population, suggesting that other factors may be of importance in the pathogenesis in this ethnic group.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
87
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 101 publications
(89 citation statements)
references
References 37 publications
2
87
0
Order By: Relevance
“…In this study, we screened the whole coding sequence of FLG gene. Interestingly, we did not detect p.R501X or c.2282del4, the most frequent mutations in Caucasians, in either 441 patients or 500 controls, implying an ethnic diVerence in the FLG mutation (Winge et al 2011a).…”
Section: Resultsmentioning
confidence: 87%
“…In this study, we screened the whole coding sequence of FLG gene. Interestingly, we did not detect p.R501X or c.2282del4, the most frequent mutations in Caucasians, in either 441 patients or 500 controls, implying an ethnic diVerence in the FLG mutation (Winge et al 2011a).…”
Section: Resultsmentioning
confidence: 87%
“…(43-45, 55, 56) These findings are in agreement with those of Winge et al, who also failed to detect common FLG loss-of-function mutations in people of African ancestry with AD. (55) Their report is from the largest whole-exome sequencing study of African Americans with AD suggesting that S2377X (FLG2) and Q294X (TCHHL1) variants may not be clinically important with respect to incident AD and it seems unlikely that FLG stop-gain mutations have a prominent role with respect to incident AD in African Americans children. (55,56) Whereas, the recent demonstration that FLG2 mutations increase the persistence of AD in African Americans (57) further suggests a pathogenic role for FLG2 mutations (rs12568784 and rs16833974) and supports the sequencing of FLG2in African Americans with IV with or without AD.…”
Section: -Filaggrin Genementioning
confidence: 99%
“…(55) Their report is from the largest whole-exome sequencing study of African Americans with AD suggesting that S2377X (FLG2) and Q294X (TCHHL1) variants may not be clinically important with respect to incident AD and it seems unlikely that FLG stop-gain mutations have a prominent role with respect to incident AD in African Americans children. (55,56) Whereas, the recent demonstration that FLG2 mutations increase the persistence of AD in African Americans (57) further suggests a pathogenic role for FLG2 mutations (rs12568784 and rs16833974) and supports the sequencing of FLG2in African Americans with IV with or without AD. (44) Polcari data was demonstrated a prevalence of filaggrin mutations including R501X, 2282del4, E2554X, R2447X, 1249insG, R826X, 2767insT, and E2422X in the African American population that exceeds previously published data, although the overall prevalence is still lower than in other populations.…”
Section: -Filaggrin Genementioning
confidence: 99%
“…A novel filaggrin gene defect has been documented in a single Ethiopian case of AD. [16] What evolutionary advantage the skin barrier defect conveyed to the populations now exposed to environmental influences precipitating atopic disease, is unknown. …”
Section: Environmentmentioning
confidence: 99%